_id
6915e694bc934aba376b1a94
Ticker
PRAX
Name
Praxis Precision Medicines Inc
Exchange
NASDAQ
Address
99 High Street, Boston, MA, United States, 02110
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://praxismedicines.com
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.
Last Close
267.28
Volume
884690
Current Price
268.8
Change
0.5686920083807389
Last Updated
2025-12-03T12:19:28.448Z
Image
data:image/webp;base64,UklGRgYCAABXRUJQVlA4IPoBAADQCwCdASpAAEAAPrVMnksnJCKhqA344BaJbADLiW88t6GNtHz7Hnk+mBknT6nMOrAa2vg78yAhl64CKyBFeSaWj4Ci7hF6UUIXvo4eXzbxIGPP/vdA/Tca0RJ9CEyUk3cof/jfLO0AAP7+EvaJ5gkBcwat3RdvBwZn97mFTNooIQtzLkEtLlxWnKp0E/jHh52x2iLK0AJp3tCts0mUi1hsO1UZa5I7EbCxVI3fB65C0IKzF9J+TCZxkWgaxBWWAQSMVKnEHF8s4JMv6VIyJMsmFTpILw4IyrI+rhZTeQOPuPZxE908ri62HatWWPBdjvhM2IJUPRZ24ALguuwbdgTkO0xkAcq3YSia+ZEMr4LQDObKhEb6rk3GoCw6n9b154obVLh+ZwMefpBJObhPa1yqP2vfGhbm1laZXFH22ffhWLWrO06d7/uNOF+w86JYXm/tfZPXPjc8JwM4XshSSzlmt6rs7/JY9ZQshtWSZo1xR55WgR+/jOMLz1qTR3pKhWBWrV+v7yyqDyoah9nmJmcOJj19lU+zxUNaEE3ylJ7mijeMX9kMCUUzvgTd+FA6JG4LofA6amYW7wRsOkZ9VSkW/UVVcerbZtW7AYSvmP7JgXwcaT7t9EOkDtboEde1otqEruwXG+HRxEuW7ht0HmRxHoOkmxW6HHwAAA==
Ipo Date
2020-10-16T00:00:00.000Z
Market Cap
4479159808
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.5473999999999999
Sentiment Sources
10
Rating
4.4167
Target Price
323.9333
Strong Buy
8
Buy
3
Hold
0
Sell
0
Strong Sell
1
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
65797000
Gross Profit
-65797000
Operating Expenses
12562000
Operating Income
-78359000
Interest Expense
-
Pretax Income
-73934000
Net Income
-73934000
Eps
-3.3641124092403114
Dividends Per Share
-
Shares Outstanding
25007171
Income Tax Expense
-
EBITDA
-73915000
Operating Margin
-
Total Other Income Expense Net
4425000
Cash
149527000
Short Term Investments
117630000
Receivables
-
Inventories
-
Total Current Assets
273844000
Property Plant Equipment
536000
Total Assets
396388000
Payables
30819000
Short Term Debt
436000
Long Term Debt
-
Total Liabilities
52883000
Equity
343505000
Depreciation
19000
Change In Working Capital
2172000
Cash From Operations
-64738000
Capital Expenditures
0
Cash From Investing
50413000
Cash From Financing
6437000
Net Change In Cash
-7888000
PE
-
PB
17.030055446762056
ROE
-21.523413050756176
ROA
-18.65192689990615
FCF
-64738000
Fcf Percent
-
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
65797000
Quarters > 0 > income Statement > gross Profit
-65797000
Quarters > 0 > income Statement > operating Expenses
12562000
Quarters > 0 > income Statement > operating Income
-78359000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-73934000
Quarters > 0 > income Statement > net Income
-73934000
Quarters > 0 > income Statement > eps
-3.3641124092403114
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
21977268
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-73915000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
4425000
Quarters > 0 > balance Sheet > cash
149527000
Quarters > 0 > balance Sheet > short Term Investments
117630000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
273844000
Quarters > 0 > balance Sheet > property Plant Equipment
536000
Quarters > 0 > balance Sheet > total Assets
396388000
Quarters > 0 > balance Sheet > payables
30819000
Quarters > 0 > balance Sheet > short Term Debt
436000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
52883000
Quarters > 0 > balance Sheet > equity
343505000
Quarters > 0 > cash Flow > net Income
-73934000
Quarters > 0 > cash Flow > depreciation
19000
Quarters > 0 > cash Flow > change In Working Capital
2172000
Quarters > 0 > cash Flow > cash From Operations
-64738000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
50413000
Quarters > 0 > cash Flow > cash From Financing
6437000
Quarters > 0 > cash Flow > net Change In Cash
-7888000
Quarters > 0 > ratios > PE
-3.3641124092403114
Quarters > 0 > ratios > PB
17.030055446762056
Quarters > 0 > ratios > ROE
-21.523413050756176
Quarters > 0 > ratios > ROA
-18.65192689990615
Quarters > 0 > ratios > FCF
-64738000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
63006000
Quarters > 1 > income Statement > gross Profit
-63006000
Quarters > 1 > income Statement > operating Expenses
13061000
Quarters > 1 > income Statement > operating Income
-76067000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-71127000
Quarters > 1 > income Statement > net Income
-71127000
Quarters > 1 > income Statement > eps
-3.312110500354671
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
21474827
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-76021000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
4940000
Quarters > 1 > balance Sheet > cash
157415000
Quarters > 1 > balance Sheet > short Term Investments
143860000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
306579000
Quarters > 1 > balance Sheet > property Plant Equipment
884000
Quarters > 1 > balance Sheet > total Assets
452832000
Quarters > 1 > balance Sheet > payables
28832000
Quarters > 1 > balance Sheet > short Term Debt
755000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
48608000
Quarters > 1 > balance Sheet > equity
404224000
Quarters > 1 > cash Flow > net Income
-71127000
Quarters > 1 > cash Flow > depreciation
-941000
Quarters > 1 > cash Flow > change In Working Capital
9365000
Quarters > 1 > cash Flow > cash From Operations
-54676000
Quarters > 1 > cash Flow > capital Expenditures
120000
Quarters > 1 > cash Flow > cash From Investing
17894000
Quarters > 1 > cash Flow > cash From Financing
28630000
Quarters > 1 > cash Flow > net Change In Cash
-8152000
Quarters > 1 > ratios > PE
-3.312110500354671
Quarters > 1 > ratios > PB
14.14109367791126
Quarters > 1 > ratios > ROE
-17.59593690626979
Quarters > 1 > ratios > ROA
-15.707149671401313
Quarters > 1 > ratios > FCF
-54796000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
60806000
Quarters > 2 > income Statement > gross Profit
-60806000
Quarters > 2 > income Statement > operating Expenses
13922000
Quarters > 2 > income Statement > operating Income
-74728000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-69296000
Quarters > 2 > income Statement > net Income
-69296000
Quarters > 2 > income Statement > eps
-3.2910593805023347
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
21055834
Quarters > 2 > income Statement > income Tax Expense
-69296000
Quarters > 2 > income Statement > EBITDA
-74681000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
5432000
Quarters > 2 > balance Sheet > cash
165567000
Quarters > 2 > balance Sheet > short Term Investments
162424000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
333575000
Quarters > 2 > balance Sheet > property Plant Equipment
1129000
Quarters > 2 > balance Sheet > total Assets
478736000
Quarters > 2 > balance Sheet > payables
22909000
Quarters > 2 > balance Sheet > short Term Debt
1066000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
39522000
Quarters > 2 > balance Sheet > equity
439214000
Quarters > 2 > cash Flow > net Income
-69296000
Quarters > 2 > cash Flow > depreciation
47000
Quarters > 2 > cash Flow > change In Working Capital
8736000
Quarters > 2 > cash Flow > cash From Operations
-52707000
Quarters > 2 > cash Flow > capital Expenditures
64000
Quarters > 2 > cash Flow > cash From Investing
-51064000
Quarters > 2 > cash Flow > cash From Financing
53966000
Quarters > 2 > cash Flow > net Change In Cash
-49805000
Quarters > 2 > ratios > PE
-3.2910593805023347
Quarters > 2 > ratios > PB
12.760617589876462
Quarters > 2 > ratios > ROE
-15.777274859180263
Quarters > 2 > ratios > ROA
-14.474783596804919
Quarters > 2 > ratios > FCF
-52771000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
7463000
Quarters > 3 > income Statement > cost Of Revenue
56288000
Quarters > 3 > income Statement > gross Profit
-48825000
Quarters > 3 > income Statement > operating Expenses
15131000
Quarters > 3 > income Statement > operating Income
-63956000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-58679000
Quarters > 3 > income Statement > net Income
-58679000
Quarters > 3 > income Statement > eps
-2.936860575673521
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
19980179
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-63909000
Quarters > 3 > income Statement > operating Margin
-856.9744070749028
Quarters > 3 > income Statement > total Other Income Expense Net
5277000
Quarters > 3 > balance Sheet > cash
215372000
Quarters > 3 > balance Sheet > short Term Investments
177195000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
404372000
Quarters > 3 > balance Sheet > property Plant Equipment
1361000
Quarters > 3 > balance Sheet > total Assets
483110000
Quarters > 3 > balance Sheet > payables
12528000
Quarters > 3 > balance Sheet > short Term Debt
1259000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
37660000
Quarters > 3 > balance Sheet > equity
445450000
Quarters > 3 > cash Flow > net Income
-58679000
Quarters > 3 > cash Flow > depreciation
47000
Quarters > 3 > cash Flow > change In Working Capital
-4918000
Quarters > 3 > cash Flow > cash From Operations
-56122000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-10918000
Quarters > 3 > cash Flow > cash From Financing
113767000
Quarters > 3 > cash Flow > net Change In Cash
46727000
Quarters > 3 > ratios > PE
-2.936860575673521
Quarters > 3 > ratios > PB
11.93921662637782
Quarters > 3 > ratios > ROE
-13.172971152766866
Quarters > 3 > ratios > ROA
-12.146095092215022
Quarters > 3 > ratios > FCF
-56122000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-7.520032158649337
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8553000
Annuals > 0 > income Statement > cost Of Revenue
152413000
Annuals > 0 > income Statement > gross Profit
-143860000
Annuals > 0 > income Statement > operating Expenses
56305000
Annuals > 0 > income Statement > operating Income
-200165000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-182819000
Annuals > 0 > income Statement > net Income
-182819000
Annuals > 0 > income Statement > eps
-10.209476916973523
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
17906794
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-199807000
Annuals > 0 > income Statement > operating Margin
-2340.289956740325
Annuals > 0 > income Statement > total Other Income Expense Net
17346000
Annuals > 0 > balance Sheet > cash
215372000
Annuals > 0 > balance Sheet > short Term Investments
177195000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
404372000
Annuals > 0 > balance Sheet > property Plant Equipment
1361000
Annuals > 0 > balance Sheet > total Assets
483110000
Annuals > 0 > balance Sheet > payables
12528000
Annuals > 0 > balance Sheet > short Term Debt
1259000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
37660000
Annuals > 0 > balance Sheet > equity
445450000
Annuals > 0 > cash Flow > net Income
-182819000
Annuals > 0 > cash Flow > depreciation
358000
Annuals > 0 > cash Flow > change In Working Capital
10921000
Annuals > 0 > cash Flow > cash From Operations
-131757000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-248494000
Annuals > 0 > cash Flow > cash From Financing
514323000
Annuals > 0 > cash Flow > net Change In Cash
134072000
Annuals > 0 > ratios > PE
-10.209476916973523
Annuals > 0 > ratios > PB
7.200303978695701
Annuals > 0 > ratios > ROE
-41.04141878998765
Annuals > 0 > ratios > ROA
-37.84210635259051
Annuals > 0 > ratios > FCF
-131757000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-15.404770256050508
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2447000
Annuals > 1 > income Statement > cost Of Revenue
86766000
Annuals > 1 > income Statement > gross Profit
-84319000
Annuals > 1 > income Statement > operating Expenses
42054000
Annuals > 1 > income Statement > operating Income
-126373000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-123277000
Annuals > 1 > income Statement > net Income
-123277000
Annuals > 1 > income Statement > eps
-18.694433205809368
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
6594316
Annuals > 1 > income Statement > income Tax Expense
264105
Annuals > 1 > income Statement > EBITDA
-125941000
Annuals > 1 > income Statement > operating Margin
-5164.405394360441
Annuals > 1 > income Statement > total Other Income Expense Net
3096000
Annuals > 1 > balance Sheet > cash
81300000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
84880000
Annuals > 1 > balance Sheet > property Plant Equipment
2652000
Annuals > 1 > balance Sheet > total Assets
87948000
Annuals > 1 > balance Sheet > payables
5815000
Annuals > 1 > balance Sheet > short Term Debt
1126000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
18279000
Annuals > 1 > balance Sheet > equity
69669000
Annuals > 1 > cash Flow > net Income
-123277000
Annuals > 1 > cash Flow > depreciation
432000
Annuals > 1 > cash Flow > change In Working Capital
-13027000
Annuals > 1 > cash Flow > cash From Operations
-111136000
Annuals > 1 > cash Flow > capital Expenditures
50000
Annuals > 1 > cash Flow > cash From Investing
38950000
Annuals > 1 > cash Flow > cash From Financing
91871000
Annuals > 1 > cash Flow > net Change In Cash
19685000
Annuals > 1 > ratios > PE
-18.694433205809368
Annuals > 1 > ratios > PB
16.95360792231839
Annuals > 1 > ratios > ROE
-176.9467051342778
Annuals > 1 > ratios > ROA
-140.17032792104425
Annuals > 1 > ratios > FCF
-111186000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-45.437678790355534
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1464000
Annuals > 2 > income Statement > cost Of Revenue
1171000
Annuals > 2 > income Statement > gross Profit
-1171000
Annuals > 2 > income Statement > operating Expenses
214986000
Annuals > 2 > income Statement > operating Income
-214986000
Annuals > 2 > income Statement > interest Expense
419000
Annuals > 2 > income Statement > pretax Income
-214029000
Annuals > 2 > income Statement > net Income
-213072000
Annuals > 2 > income Statement > eps
-69.33418718980995
Annuals > 2 > income Statement > dividends Per Share
811000
Annuals > 2 > income Statement > shares Outstanding
3073116
Annuals > 2 > income Statement > income Tax Expense
-957000
Annuals > 2 > income Statement > EBITDA
-214567000
Annuals > 2 > income Statement > operating Margin
-14684.83606557377
Annuals > 2 > income Statement > total Other Income Expense Net
957000
Annuals > 2 > balance Sheet > cash
61615000
Annuals > 2 > balance Sheet > short Term Investments
38874000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
110840000
Annuals > 2 > balance Sheet > property Plant Equipment
3872000
Annuals > 2 > balance Sheet > total Assets
115128000
Annuals > 2 > balance Sheet > payables
14672000
Annuals > 2 > balance Sheet > short Term Debt
1005000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
39022000
Annuals > 2 > balance Sheet > equity
76106000
Annuals > 2 > cash Flow > net Income
-214029000
Annuals > 2 > cash Flow > depreciation
419000
Annuals > 2 > cash Flow > change In Working Capital
-1781000
Annuals > 2 > cash Flow > cash From Operations
-185043000
Annuals > 2 > cash Flow > capital Expenditures
444000
Annuals > 2 > cash Flow > cash From Investing
96889000
Annuals > 2 > cash Flow > cash From Financing
10465000
Annuals > 2 > cash Flow > net Change In Cash
-77689000
Annuals > 2 > ratios > PE
-69.33418718980995
Annuals > 2 > ratios > PB
7.232559487294037
Annuals > 2 > ratios > ROE
-279.9674138701285
Annuals > 2 > ratios > ROA
-185.07400458619972
Annuals > 2 > ratios > FCF
-185487000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-126.69877049180327
Annuals > 2 > health Score
22
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1594000
Annuals > 3 > income Statement > gross Profit
-1594000
Annuals > 3 > income Statement > operating Expenses
167332000
Annuals > 3 > income Statement > operating Income
-167332000
Annuals > 3 > income Statement > interest Expense
182000
Annuals > 3 > income Statement > pretax Income
-167061000
Annuals > 3 > income Statement > net Income
-166879000
Annuals > 3 > income Statement > eps
-58.96221915223636
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2830270
Annuals > 3 > income Statement > income Tax Expense
-182000
Annuals > 3 > income Statement > EBITDA
-167150000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
271000
Annuals > 3 > balance Sheet > cash
138704000
Annuals > 3 > balance Sheet > short Term Investments
137207000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
287409000
Annuals > 3 > balance Sheet > property Plant Equipment
4866000
Annuals > 3 > balance Sheet > total Assets
292747000
Annuals > 3 > balance Sheet > payables
10780000
Annuals > 3 > balance Sheet > short Term Debt
4311000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
41935000
Annuals > 3 > balance Sheet > equity
250812000
Annuals > 3 > cash Flow > net Income
-167061000
Annuals > 3 > cash Flow > depreciation
182000
Annuals > 3 > cash Flow > change In Working Capital
16133000
Annuals > 3 > cash Flow > cash From Operations
-124554000
Annuals > 3 > cash Flow > capital Expenditures
1050000
Annuals > 3 > cash Flow > cash From Investing
-140520000
Annuals > 3 > cash Flow > cash From Financing
107586000
Annuals > 3 > cash Flow > net Change In Cash
-157488000
Annuals > 3 > ratios > PE
-58.96221915223636
Annuals > 3 > ratios > PB
2.021210352973542
Annuals > 3 > ratios > ROE
-66.53549271964658
Annuals > 3 > ratios > ROA
-57.00451242882079
Annuals > 3 > ratios > FCF
-125604000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-3.3641124092403114
Valuation > metrics > PB
17.030055446762056
Valuation > final Score
20
Valuation > verdict
467.7% Overvalued
Profitability > metrics > ROE
-21.523413050756176
Profitability > metrics > ROA
-26.998583134923532
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.15395117974993086
Risk > metrics > Interest Coverage
-4124.1578947368425
Risk > final Score
-16437
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.761606143017117
Liquidity > metrics > Quick Ratio
8.761606143017117
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-2
Prev Risks > 1
4
Prev Risks > 2
11
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-12T21:09:51.111Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-04
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-3.37
Earnings History > 0 > eps Difference
3.37
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-05
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-3.36
Earnings History > 1 > eps Estimate
-3.47
Earnings History > 1 > eps Difference
0.11
Earnings History > 1 > surprise Percent
3.17
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-04
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-3.31
Earnings History > 2 > eps Estimate
-3.25
Earnings History > 2 > eps Difference
-0.06
Earnings History > 2 > surprise Percent
-1.8462
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-12
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-3.29
Earnings History > 3 > eps Estimate
-2.07
Earnings History > 3 > eps Difference
-1.22
Earnings History > 3 > surprise Percent
-58.9372
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-03
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-2.94
Earnings History > 4 > eps Estimate
-2.8191
Earnings History > 4 > eps Difference
-0.1209
Earnings History > 4 > surprise Percent
-4.2886
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-05
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-2.75
Earnings History > 5 > eps Estimate
-1.99
Earnings History > 5 > eps Difference
-0.76
Earnings History > 5 > surprise Percent
-38.191
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.74
Earnings History > 6 > eps Estimate
-2.31
Earnings History > 6 > eps Difference
0.57
Earnings History > 6 > surprise Percent
24.6753
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-13
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-2.84
Earnings History > 7 > eps Estimate
-2.08
Earnings History > 7 > eps Difference
-0.76
Earnings History > 7 > surprise Percent
-36.5385
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-05
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-2.97
Earnings History > 8 > eps Estimate
-3.18
Earnings History > 8 > eps Difference
0.21
Earnings History > 8 > surprise Percent
6.6038
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-07
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.18
Earnings History > 9 > eps Estimate
-0.35
Earnings History > 9 > eps Difference
0.17
Earnings History > 9 > surprise Percent
48.5714
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.49
Earnings History > 10 > eps Estimate
-0.66
Earnings History > 10 > eps Difference
0.17
Earnings History > 10 > surprise Percent
25.7576
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.71
Earnings History > 11 > eps Estimate
-0.79
Earnings History > 11 > eps Difference
0.08
Earnings History > 11 > surprise Percent
10.1266
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-07
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.87
Earnings History > 12 > eps Estimate
-0.78
Earnings History > 12 > eps Difference
-0.09
Earnings History > 12 > surprise Percent
-11.5385
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-09
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.96
Earnings History > 13 > eps Estimate
-0.89
Earnings History > 13 > eps Difference
-0.07
Earnings History > 13 > surprise Percent
-7.8652
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-08
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.32
Earnings History > 14 > eps Estimate
-1.3
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-1.5385
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.51
Earnings History > 15 > eps Estimate
-1.3
Earnings History > 15 > eps Difference
-0.21
Earnings History > 15 > surprise Percent
-16.1538
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-1.3
Earnings History > 16 > eps Estimate
-1.08
Earnings History > 16 > eps Difference
-0.22
Earnings History > 16 > surprise Percent
-20.3704
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-03
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-1
Earnings History > 17 > eps Estimate
-0.93
Earnings History > 17 > eps Difference
-0.07
Earnings History > 17 > surprise Percent
-7.5269
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.88
Earnings History > 18 > eps Estimate
-0.67
Earnings History > 18 > eps Difference
-0.21
Earnings History > 18 > surprise Percent
-31.3433
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.71
Earnings History > 19 > eps Estimate
-0.74
Earnings History > 19 > eps Difference
0.03
Earnings History > 19 > surprise Percent
4.0541
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-17
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.87
Earnings History > 20 > eps Estimate
-0.37
Earnings History > 20 > eps Difference
-0.5
Earnings History > 20 > surprise Percent
-135.1351
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-23
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-12.1
Earnings History > 21 > eps Estimate
-0.73
Earnings History > 21 > eps Difference
-11.37
Earnings History > 21 > surprise Percent
-1557.5342
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-02
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-3.9
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-3.9
Earnings History > 22 > surprise Percent
-
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APraxis Precision Medicines (PRAX): Revisiting Valuation After Major FDA Progress and Positive CNS Trial Updates simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$323.9333
Analyst Picks
Strong Buy
8
Buy
3
Hold
0
Sell
0
Strong Sell
1
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 120.99% of the total shares of Praxis Precision Medicines Inc
1.
HHG PLC(12.0354%)
since
2025/06/30
2.
Adage Capital Partners Gp LLC(9.3806%)
since
2025/06/30
3.
Cormorant Asset Management, LLC(7.7199%)
since
2025/06/30
4.
BlackRock Inc(7.5542%)
since
2025/06/30
5.
T. Rowe Price Associates, Inc.(6.9981%)
since
2025/06/30
6.
Morgan Stanley - Brokerage Accounts(5.826%)
since
2025/06/30
7.
Vanguard Group Inc(5.7751%)
since
2025/06/30
8.
Soleus Capital Management, L.P.(4.5927%)
since
2025/06/30
9.
Point72 Asset Management, L.P.(4.5325%)
since
2025/06/30
10.
Perceptive Advisors LLC(3.5769%)
since
2025/06/30
11.
State Street Corp(3.3164%)
since
2025/06/30
12.
Baker Bros Advisors LP(3.2755%)
since
2025/06/30
13.
Deerfield Management Co(3.2634%)
since
2025/06/30
14.
Vanguard Total Stock Mkt Idx Inv(3.199%)
since
2025/07/31
15.
Assenagon Asset Management SA(2.8708%)
since
2025/06/30
16.
Driehaus Capital Management LLC(2.5226%)
since
2025/06/30
17.
Bank of America Corp(2.154%)
since
2025/06/30
18.
Geode Capital Management, LLC(2.146%)
since
2025/06/30
19.
iShares Russell 2000 ETF(2.0438%)
since
2025/08/31
20.
Janus Henderson Global Life Sciences D(1.9119%)
since
2025/06/30
21.
Janus Henderson Global Life Sciences(1.9119%)
since
2025/06/30
22.
US Small-Cap Growth II Equity Comp(1.8692%)
since
2025/06/30
23.
CIBC Global Asset Management Inc(1.8469%)
since
2025/06/30
24.
Renaissance Global Health Care(1.845%)
since
2025/05/31
25.
Balyasny Asset Management LLC(1.7542%)
since
2025/06/30
26.
Janus Global Life Science AUSD(1.5925%)
since
2025/06/30
27.
Janus Henderson Glb Life Scn I2 USD(1.557%)
since
2025/07/31
28.
Franklin Resources Inc(1.4924%)
since
2025/06/30
29.
SPDR® S&P Biotech ETF(1.4358%)
since
2025/08/31
30.
T. Rowe Price Health Sciences(1.4211%)
since
2025/07/31
31.
T. Rowe Price New Horizons(1.2509%)
since
2025/07/31
32.
T. Rowe Price Integrated US Sm Gr Eq(1.2278%)
since
2025/07/31
33.
T. Rowe Price Integrated US SmCapGrEq(1.2278%)
since
2025/06/30
34.
Janus Henderson Hrzn Biotec E2 USD(1.0077%)
since
2025/06/30
35.
Vanguard Institutional Extnd Mkt Idx Tr(0.9757%)
since
2025/07/31
36.
Franklin Biotechnology Discv A(acc)USD(0.952%)
since
2025/08/31
37.
Fidelity Small Cap Index(0.8496%)
since
2025/06/30
38.
Invesco MSCI World ETF(0.8182%)
since
2025/07/31
39.
iShares Russell 2000 Value ETF(0.6844%)
since
2025/08/31
40.
T. Rowe Price New Horizons Tr-A(0.5737%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-3.37
Date
2025-09-30
EPS Actual
-3.36
EPS Estimate
-3.47
EPS Difference
0.11
Surprise Percent
3.17%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.